Foci Pharmaceutical(SZ:002644)2026-01-30 09:00Group 1: Company Performance and Strategy - The company plans to disclose its 2025 annual report on April 9, 2026, detailing specific operational performance [2] - The company aims to strengthen its core product system and enhance brand influence by focusing on traditional products and unique varieties [2] - The company has a reasonable inventory level, with turnover rates aligning with industry standards [5] Group 2: Market Expansion and Investment - The company has been exporting since 1931 and currently sells products in 32 countries, with 1,442 overseas product registrations [4] - In October 2025, the company invested 20 million yuan in KJT Technology Co., Ltd. to enter the radioactive isotope drug sector [5] - The company is committed to enhancing its international strategy and expanding its overseas market share [4] Group 3: Future Development Plans - During the 14th Five-Year Plan, the company will focus on modernizing and internationalizing traditional Chinese medicine [6] - The company aims to optimize production line structures and enhance technological innovation to strengthen its core competitiveness [6]